This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Feb;10(2):60.

doi: 10.1038/nrcardio.2012.192. Epub 2012 Dec 18.

MRA use in patients with HFrEF

Bryony M Mearns

PMID: 23247312
DOI: 10.1038/nrcardio.2012.192

Comment

MRA use in patients with HFrEF

Bryony M Mearns. Nat Rev Cardiol. 2013 Feb.

. 2013 Feb;10(2):60.

doi: 10.1038/nrcardio.2012.192. Epub 2012 Dec 18.

Author

Bryony M Mearns

PMID: 23247312
DOI: 10.1038/nrcardio.2012.192

No abstract available

PubMed Disclaimer

Comment on

Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction.
Hernandez AF, Mi X, Hammill BG, Hammill SC, Heidenreich PA, Masoudi FA, Qualls LG, Peterson ED, Fonarow GC, Curtis LH. Hernandez AF, et al. JAMA. 2012 Nov 28;308(20):2097-107. doi: 10.1001/jama.2012.14795. JAMA. 2012. PMID: 23188026

References

1. JAMA. 2012 Nov 28;308(20):2097-107 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.